Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

BACKGROUND: Cytochrome P450 2D6 (CYP2D6) is responsible for the metabolism of clinically used drugs and other environmental exposures, but it is unclear whether the CYP2D6 phenotype is associated with adverse health outcomes. The aim was to determine the association of CYP2D6 phenotype with the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Paul Y, Ryu, Euijung, Pathak, Jyotishman, Jenkins, Gregory D, Batzler, Anthony, Hathcock, Matthew A, Black, John Logan, Olson, Janet E, Cerhan, James R, Bielinski, Suzette J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317339/
https://www.ncbi.nlm.nih.gov/pubmed/28243137
http://dx.doi.org/10.2147/PGPM.S114211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317339/
https://www.ncbi.nlm.nih.gov/pubmed/28243137
http://dx.doi.org/10.2147/PGPM.S114211

Ejemplares similares